Clinical Trials Directory

Trials / Unknown

UnknownNCT02867787

Study of the Treatment of Tendinopathy Unruptured of Rotator Cuff by Intramuscular Injection of Botulinum Toxin

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Versailles Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Botulinum toxin is used in musculoskeletal therapy routinely for 15 years. This is one of the most potent neurotoxins. It comes in 7 serotypes (A to G).Therapeutic application of botulinum toxin are mainly based on its ability to block the neuromuscular transmission by preventing the release of acetylcholine, creating paralysis muscle relative and reversible. It has been used in the treatment of cervical dystonia, migraine headaches, and an antinociceptive effect. The analgesic effect occurred even prior to the release muscular. Several randomized studies have been published about it. The investigators assume that intramuscular injection of botulinum toxin is effective in the treatment of tendinopathy rotator cuff.

Conditions

Interventions

TypeNameDescription
DRUGBotox arm

Timeline

Start date
2014-03-01
Primary completion
2016-09-01
Completion
2016-09-01
First posted
2016-08-16
Last updated
2016-08-18

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02867787. Inclusion in this directory is not an endorsement.